Articles

High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: TMTV is a useful risk factor to stratify patients at baseline

Department of Hematology, Dijon-Bourgogne University Hospital, Dijon; INSERM unit 1231, University of Burgundy Franche-Comté, France
Department of Hematology, CHU UCL Namur, Université Catholique de Louvain, Yvoir, Belgium
Lymphoid Malignancies Unit, Henri Mondor University Hospital (AP-HP), Créteil, France
Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA), Department of Haematology, CHU Lille, Université de Lille, Lille
Department of Hematology, Hospital Sud Francilien, Corbeille-Essonnes, France
Department of Hematology, Université Paris-Saclay, Gustave Roussy, Villejuif, France
Department of Hematology, Centre Hospitalier Lyon Sud and Université Claude Bernard Lyon-1, Pierre-Bénite, France
Department of Hematology, Centre Henri Becquerel, Rouen, France
Department of Hematology, Centre Léon Bérard, Lyon, France
Hospital of Nancy, Vandoeuvre les Nancy, France
Department of Haematology, Institut d'hématologie de Basse Normandie, Caen, France
Department of Hematology, CHU Paris-GH St-Louis Lariboisière F-Widal - Hôpital Saint-Louis, Paris, France
Department of Haematology, University Hospital of Strasbourg, Strasbourg, France
Department of Hematology, CHU Cochin, Paris, France
Lymphoma Academic Research Organisation, CHU Lyon-Sud, Lyon, France
European Organisation for Research and Treatment of Cancer, Brussels, Belgium
Department of Haematology, Radboud University Medical Center, Nijmegen, Netherlands
CHIMOMO department, University of Modena and Reggio Emilia, Policlinico, Modena, Italy
Nuclear Medecine Unit, Institut universitaire du cancer Toulouse-Oncopole, Toulouse, France
LYSA Imaging, University Hospital H Mondor, Creteil, France
Department of Pathology, Centre Hospitalier Lyon Sud and Université Claude Bernard Lyon-1, Pierre- Bénite, France
Nuclear Medecine Department, Hôpital Cochin, AP-HP, Université de Paris, France
Department of Hematology, Dijon-Bourgogne University Hospital, Dijon; INSERM unit 1231, University of Burgundy Franche-Comté, France
Haematologica Early view May 31, 2022 https://doi.org/10.3324/haematol.2021.280004